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BACKGROUND: Optimal healing of the myocardium after myocardial 
infarction (MI) requires a suitable degree of inflammation and its timely 
resolution, together with a well-orchestrated deposition and degradation 
of ECM (extracellular matrix) proteins.
METHODS AND RESULTS: MI and SHAM-operated animals were 
imaged at 3, 7, 14, and 21 days with 3T magnetic resonance imaging 
using a 19F/1H surface coil. Mice were injected with 19F-perfluorocarbon 
nanoparticles to study inflammatory cell recruitment, and with a 
gadolinium-based elastin-binding contrast agent to evaluate elastin 
content. 19F magnetic resonance imaging signal colocalized with 
infarction areas, as confirmed by late gadolinium enhancement, and was 
highest 7 days post-MI, correlating with macrophage content (MAC-
3 immunohistochemistry; ρ=0.89, P<0.0001). 19F quantification with 
in vivo (magnetic resonance imaging) and ex vivo nuclear magnetic 
resonance spectroscopy correlated linearly (ρ=0.58, P=0.020). T1 
mapping after gadolinium-based elastin-binding contrast agent injection 
showed increased relaxation rate (R1) in the infarcted regions and was 
significantly higher at 21 days compared with 7 days post-MI (R1 [s
−1]: 21 
days=2.8 [interquartile range, 2.69–3.30] versus 7 days=2.3 [interquartile 
range, 2.12–2.5], P<0.05), which agreed with an increased tropoelastin 
content (ρ=0.89, P<0.0001). The predictive value of each contrast agent 
for beneficial remodeling was evaluated in a longitudinal proof-of-
principle study. Neither R1 nor 
19F at day 7 were significant predictors for 
beneficial remodeling (P=0.68; P=0.062). However, the combination of 
both measurements (R1<2.34 Hz and 0.55≤
19F≤1.85) resulted in an odds 
ratio of 30.0 (CI 95%, 1.41–638.15; P=0.029) for favorable post-MI 
remodeling.
CONCLUSIONS: Multinuclear 1H/19F magnetic resonance imaging allows 
the simultaneous assessment of inflammation and elastin remodeling in 
a murine MI model. The interplay of these biological processes affects 
cardiac outcome and may have potential for improved diagnosis and 
personalized treatment.
© 2018 The Authors. Circulation: 
Cardiovascular Imaging is published 
on behalf of the American Heart 
Association, Inc., by Wolters Kluwer 
Health, Inc. This is an open access 
article under the terms of the Creative 
Commons Attribution License, 
which permits use, distribution, and 
reproduction in any medium, provided 
that the original work is properly cited.
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Cardiac injury activates innate immunity, which initiates an inflammatory response whereby neutrophils and monocytes/macrophages are re-
cruited to the myocardium.1 Immediately after myocar-
dial infarction (MI), neutrophils are recruited to the site 
of injury, followed by the recruitment of monocytes/
macrophages that remove dead cells and debris by 
phagocytosis.1,2 Studies have shown that an early and 
aggressive immune response and high levels of neutro-
phils and monocytes within the infarct may promote 
adverse remodeling and lead to poor prognosis.3,4 In 
addition to their phagocytic properties, inflammatory 
cells activate reparative pathways, including the for-
mation and deposition of scar tissue, which is mainly 
composed of collagen and elastin/tropoelastin.2,5,6 Elas-
tin has been shown to be essential for the stabilization 
of the scar after MI and improving cardiac function by 
preserving elasticity.7,8 While the healthy myocardium 
contains elastin only to a negligible degree within the 
interstitium and coronary vasculature, an increase of 
elastic fibers within the myocardial scar is detected in 
the first weeks after ischemic injury developing a dense 
network between the remaining viable myocytes, myo-
fibroblasts, and smooth muscle cells during the matura-
tion of the infarct.5 Tropoelastin, the soluble precursor 
of elastin, is synthesized in significant amounts and de-
posited within the remodeled myocardium, particularly 
at later stages of the healing process.9
Magnetic resonance imaging (MRI) has great poten-
tial to noninvasively assess both structure and function 
of the heart. By combining MRI with specific contrast 
agents, different biological processes can be target-
ed and tracked over time. In this study, we sought to 
explore the merits of multinuclear 1H/19F MRI for the 
sequential assessment and quantification of cardiac 
inflammation and elastin remodeling in a murine mod-
el of MI using a 3T clinical scanner. Perfluorocarbons 
(PFCs) were used to assess inflammatory cell recruit-
ment and gadolinium-based elastin-specific magnetic 
resonance contrast agent (Gd-ESMA) was used for the 
investigation of elastin deposition and quantification of 
ECM (extracellular matrix) remodeling of the myocar-
dium. This approach may potentially allow a more accu-
rate characterization of early or persistent inflammation 
and diffuse myocardial remodeling at the molecular lev-
el. It may also serve as a new biomarker for monitoring 
treatment response and evaluation of novel cardiopro-
tective therapies.
METHODS
The DICOM MR images will be made available to other 
researchers for purposes of reproducing the results.10
Animal Model
The institutional subcommittee on research animal care 
approved all animal studies. MI was induced in 10-week-old 
female C57BL/6J mice (n=71; 21% mortality rate; Charles 
River, United Kingdom) by permanent occlusion of the left 
anterior descending (LAD) coronary artery. Mice were anes-
thetized by intraperitoneal injection of 75 mg/kg ketamine 
(Vetalar V, Vetmedica) and 1 mg/kg medetomidine hydrochlo-
ride (Domitor, Orion Corporation, Finland). The animals under-
went endotracheal intubation before surgery using an animal 
ventilator (Hugo Sacks Elektronic, Germany). A left thoracot-
omy was performed in the fourth intercostal space, the peri-
cardium removed, and the LAD was permanently ligated with 
an 8-0 nylon suture (Direct Medical Supplies, Alton, United 
Kingdom). Successful ligation was confirmed by the regional 
blanching of the left ventricle (LV), extending to the apex. 
After thoracotomy, subcutaneous tissue and skin were closed 
in separate layers and the animal was weaned from the venti-
lator. After the surgery, mice were monitored and maintained 
in a heated chamber for at least 6 hours. Sham-operated ani-
mals underwent the same surgical procedure, without LAD 
ligation. Thirty minutes before recovery, 0.15 mg/kg buprenor-
phine (Vetergesic, Alstoe, United Kingdom) was administered 
for analgesia by intramuscular injection.
CLINICAL PERSPECTIVE
Here, we developed a new multinuclear magnetic 
resonance imaging protocol that allows visualiz-
ing and quantifying myocardial inflammation and 
ECM (extracellular matrix) remodeling simultane-
ously in a murine model of permanent coronary 
occlusion. The imaging approach is based on 19F/1H 
multinuclear magnetic resonance imaging in con-
cert with fluorine nanoparticles and a gadolinium-
based elastin-specific magnetic resonance contrast 
agent. This is the first study that assessed inflam-
mation and ECM remodeling simultaneously with 
a single noninvasive imaging modality and could 
provide important insights in post-infarct remodel-
ing in patients developing heart failure. We also 
demonstrated the prognostic value of quantifying 
inflammation and ECM remodeling 7 days post-
MI. A well-balanced inflammatory response was 
beneficial for maintaining left ventricular function, 
whereas extensive ECM remodeling was detrimen-
tal. If translated into the clinic, this work could 
provide clinicians with a new tool to noninvasively 
assess inflammation and ECM remodeling (focal 
and diffuse fibrosis), which is not possible with 
currently available contrast agents or noncontrast 
enhanced imaging methods. In summary, we dem-
onstrated the feasibility of measuring myocardial 
inflammation and ECM remodeling (fibrosis) non-
invasively, 2 key processes in tissue injury, and has 
great potential beyond cardiac imaging such as for 
the assessment of renal, liver or lung inflamma-
tion, and fibrosis.
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Magnetic Resonance Imaging
In vivo cardiac scans were performed using a 3T Philips 
Achieva MR scanner (Philips Healthcare, Best, The 
Netherlands) equipped with a clinical gradient system (30 
mT/m, 200 mT/m per ms). Mice (n=8 per time-point) were 
imaged at 3, 7, 14, and 21 days post-MI. Sham-operated 
mice (n=6 per time-point) were imaged at the same time-
points and were used as controls (Figure 1A). Fifteen mice 
were imaged longitudinally at 7 and 21 days post-MI 
(Figure 1B). Animals were placed in a prone position on a 
19F/1H surface coil (Rapid Biomedical, Würzburg, Germany; 
diameter=23 and 33 mm). Anesthesia was induced with 
5% and maintained with 1.5% to 2% isoflurane in medi-
cal oxygen during the MRI scan, and the body temperature 
was measured with a rectal temperature probe and main-
tained at 35±1ºC using a water-based heating system (SA 
Instruments, Stony Brook, NY). ECG was monitored with 2 
metallic needles placed subcutaneously in the region of the 
chest. 1H and 19F cardiac ECG-triggered MR images were 
acquired 48 hours after intravenous injection of 400 μL of 
10% perfluoro-15-crown-5 ether emulsion (PFC), as previ-
ously described11 and 0.5 mmol/kg of a gadolinium-based 
MRI contrast agent that targets elastin and tropoelastin, 
Gd-ESMA (Lantheus Medical Imaging, North Billerica, MA), 
administered 1 hour before the MRI scan. At the end of the 
scans, the mice were culled and the heart was extracted for 
histological and nuclear magnetic resonance (NMR) studies.
After a 3-dimensional (3D) gradient echo scout scan, 2D 
cine short-axis images, covering the entire LV, were acquired to 
analyze functional and volumetric parameters. Imaging param-
eters were field-of-view (FOV)=35×35×12 mm3, acquired in-
plane resolution=0.3×0.3×1 mm3, slices=12, repetition time 
(TR)/echo time=7.8/16.0 ms, flip angle=20°. Subsequently, a 
2D Look-Locker scan planned perpendicular to the LV was 
used to determine the optimal inversion time for nulling of 
the healthy myocardium. Three-dimensional short-axis late 
gadolinium enhancement (LGE) gradient echo images were 
acquired between 60 and 80 minutes after Gd-ESMA injection 
for the visualization of contrast uptake within the infarcted 
region with the following parameters: FOV=35×35×12 mm3, 
acquired in-plane resolution=0.3×0.3×1 mm3, slices=12, TR/
TE=6.4/2.6 ms, 5 heartbeats between subsequent inversion 
recovery pulses, and flip angle=25°. T1 mapping was per-
formed using a 2D Modified Look-Locker inversion recovery 
sequence.12 The inversion pulse was followed by 8 segmented 
readouts, each spaced 1 R-R intervals in cardiac gating apart, 
for 8 individual images resulting in inversion time’s ranging 
from 10 to 2000 ms. To allow full magnetization recovery, 
12 pauses/heartbeats were performed before the next inver-
sion pulse. Acquisition parameters included FOV=35×35×1.5 
mm3, acquired in-plane resolution=0.3×0.3 mm2, slices=1, 
TR/TE=7.5/3.1 ms, flip angle=16 °. For the visualization of 
the inflammatory cells, a 3D turbo spin echo 19F scan was 
acquired with a FOV=35×35×12 mm3, acquired in plane reso-
lution=1×1×2 mm3, slices=12, TR/TE=4 beats/8.9 ms, turbo 
spin echo factor=5, offset frequency=10 200 Hz (BW=6103 
Hz). A saturation slice was used to suppress the liver signal. 
To enable signal-to-noise (SNR) calculation, a noise scan was 
acquired with the same imaging parameters but without any 
radiofrequency pulses to correct for local noise variability. A 
T2-weighted sequence was used to analyze edema within the 
heart at 3 and 7 days post-MI, with the following parameters: 
FOV=35×35×1.5 mm3, acquired in-plane resolution=0.3×0.3 
mm2, slices=3, TR/TE=126/18 ms, flip angle=30°.
MR Image Analysis
Ejection fraction (%), LV end-diastolic volume (LVEDV, μL) and 
LV mass (mg) were calculated from the cine images, using an 
automated segmentation software (ClinicalVolumes, King’s 
College London, www.clinicalvolumes.com).13 Total infarct size 
was calculated by adding the LGE measured on consecutive 
slices after the administration of Gd-ESMA (LGE-ESMA). The 
sum of the total infarcted area was multiplied by the slice thick-
ness to generate a volume (mm3) and was then divided by the 
total LV myocardium and expressed as percentage. T1 relax-
ation times (R1) were calculated by manually segmenting T1 
map regions corresponding to the LGE-ESMA using OsiriX 
(Osirix Foundation, Geneva, Switzerland). For 19F measure-
ments, regions of interest were defined as areas of enhance-
ment seen on the LGE-ESMA images. For these areas, 19F 
Figure 1.  Experimental study design.  
Myocardial infarction was induced in C57Bl6 
female mice after permanent occlusion of 
the left anterior descending (LAD) coronary 
artery. Magnetic resonance imaging (MRI) 
scans were performed after intravenous injec-
tion of 19F perfluorocarbons (19F PFCs) and 
gadolinium-based elastin/tropoelastin specific 
MR contrast agent (Gd-ESMA), 48 and 1 h 
before imaging sessions, respectively. A, Mice 
(n=8 per group/time-point) were imaged at 3, 
7, 14, and 21 days post-myocardial infarction 
(MI). SHAM-operated mice (n=6 per group/
time-point) were imaged at the same time-
points and were used as controls. At the end 
of the scans, mice were culled and hearts 
were extracted for histology and nuclear 
magnetic resonance (NMR; n=4/group and 
3-SHAM-operated animals/time-point for 
each technique). B, 15 mice were imaged lon-
gitudinally at 7 and 21 days post-MI.
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signal was calculated using the following equation: 
19Fsignal
SNR
scar volume
=
∑ , where SNR is the sum of the signal of 
the infarcted area divided by the SD of the noise in each slice, 
and scar volume was calculated from the sum of the LGE-ESMA 
area of each slice multiplied by the MRI slice thickness.14
Nuclear Magnetic Resonance Spectroscopy
NMR spectroscopy was used to quantify the uptake of PFC ex 
vivo. Mice injected with PFC and scanned at 3T were culled 
and the hearts were collected (MI, n=4; SHAM, n=3; each per 
time-point). Remote and infarcted regions were separated, 
weighed and frozen at −20ºC before NMR analysis. NMR spec-
tra of the PFCs were recorded at room temperature using a 
Bruker Avance III 9.4T scanner (1H 400 MHz; 19F 375.8 MHz) 
and a 15-mm-diameter-large, double-tuned (31P/1H) volumet-
ric microimaging coil. The water resonance was used to shim 
the sample and the 1H coil was then retuned to the 19F fre-
quency. Both remote and infarcted areas were placed in NMR 
tubes (Fisher Scientific, Leicestershire, United Kingdom) with a 
silicone support to position the sample within the isocentre of 
the coil. A sealed external reference capillary of 100% trifluo-
roacetic acid (TFA) solution (δ-TFA=−76.6 ppm as identified in 
the literature, and reported relative to CFCl3) was placed adja-
cent to the heart. The 19F NMR chemical shift of the PFC peak 
was −12.5 ppm relative to the reference capillary. A 90o radio-
frequency pulse (30 µs hard pulse) was used together with 
many signal averages=64, total experiment duration=4.78 
min, time domain size=131 K data points, prescan delay=1 
second, acquisition time=3.5 seconds to give a total repetition 
time of TR=4.5 seconds per scan, spectral bandwidth=18 797 
Hz. Data were processed with an exponential line broadening 
factor (20 Hz), followed by Fourier transformation, zero- and 
first-order phase correction and automatic baseline correction. 
Peaks corresponding to the TFA reference and the PFC were 
integrated using Topspin 2.1 software (Bruker Biospin GmbH, 
Rheinstetten, Germany) and normalized to the reference capil-
lary. The number of moles of 19F was calculated using the 
equation PFC
N I TFA
N I g
TFA PFC
PFC TFA tissue
[ ] = [ ]× ×
× ×
, where [PFC] is the concen-
tration per gram tissue (wet weight), NTFA is the number of 
19F 
nuclei giving rise to the TFA signal, NPFC is the number of 
19F 
nuclei giving rise to the PFC signal, IPFC is the peak integral of 
the PFC peak, ITFA is the peak integral of the TFA peak (ITFA=1, 
normalized), [TFA] is the number of moles of TFA.
Histology
After the MRI scans, anesthetized mice were culled by neck 
dislocation and hearts were collected for ex vivo analysis (n=4 
MI mice per time-point, and n=3 SHAM-operated animals 
per time-point). Hearts were harvested, the atriums were 
removed and the ventricles were washed in saline solution 
followed by immersion in 10% formaldehyde solution for 24 
hours at room temperature. Hearts were then dehydrated, 
paraffin-embedded, and transversely sectioned (5 μm thick).
Immunohistochemistry (IHC) was used to quantify the 
amount of tropoelastin and macrophages in the myocardium. 
Tropoelastin was detected with anti-mouse rabbit polyclonal 
antibody (21600, Abcam; dilution 1:100) using an avidin-bio-
tin-peroxidase method (Vector SG Peroxidase substrate; Vector 
Laboratories, Burlingame, CA). A monoclonal rat anti-mouse 
antibody (550292, BD Pharmingen; CD107b; MAC-3; dilu-
tion 1:100) was used for macrophage detection. The antibody 
was revealed with streptavidin-peroxidase (Dako, Ely, United 
Kingdom; ABC kit, 1:100). Digital images were analyzed using 
ImageJ (National Institute of Health, Bethesda, MD). Tropoelastin 
and MAC-3 were quantified and expressed as percentage of the 
infarcted myocardium using ImageJ, and were manually seg-
mented and normalized with the total area of infarction for each 
histology slice calculated from Masson’s trichrome staining.
Statistical Analysis
GraphPad Prism 5.00 (GraphPad Software, Inc, La Jolla, CA) 
was used for statistical analysis. Nonparametric exact tests were 
used for analysis. Differences between different time-point 
measurements were analyzed using Kruskal-Wallis test for mul-
tiple group comparisons, and if this test was significant, it was 
followed by Dunn’s post hoc test. Differences between differ-
ent time-points and different groups: SHAM/scar/remote were 
analyzed using a 2-way ANOVA. Correlations were assessed 
using Spearman rank test. To study the nonlinear behavior of 
19F in the longitudinal study, the linear correlation model was 
compared with second-order polynomial model regression; 
both variables (EDV at day 21 and 19F SNR) were first tested 
for normal distribution using the D’Agostino-Pearson omnibus 
normality test. Receiver operating characteristic curve analysis 
was performed to identify the cutoff point of imaging biomark-
ers to predict the evolution of functional cardiac parameters; in 
this case, the increase in the LVEDV between day 7 and day 21 
was considered as dysfunctional remodeling, and the decrease 
of EDV between day 7 and day 21 was considered as a benefi-
cial remodeling. P<0.05 was considered statistically significant. 
Data are presented as median, and interquartile range (IQR).
RESULTS
Assessment of Cardiac Function by MRI 
at 3T
Cardiac function was assessed using cine MRI and 
results are summarized in Figure 2 (detailed results in 
Table I in the Data Supplement). A visual enlargement 
of the LV and thinning of the ventricular wall at the 
site of the infarction was observed post-MI and became 
more evident at day 21. These results are consistent 
with previous studies in the same animal model.15
Assessment of the Inflammatory 
Response in Post-MI Remodeling  
Using PFCs
Myocardial remodeling post-MI is associated with an 
acute inflammatory response. Combined proton (1H) 
and fluorine (19F) images confirmed colocalization of 
the PFCs within the infarcted area at both 3 and 7 days 
(Figure 3A).
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Quantitative in vivo 19F MRI showed a significant 
increase of 19F signal (SNR/scar volume) within the infarct-
ed area at 7 days post-MI (SNR=1.27 [IQR, 0.84–1.58]) 
compared with SHAM-operated animals (SNR=0.19 
[IQR, 0.13–0.20]; P<0.001) (Figure 3B). A maximum 19F 
signal was observed at 7 days post-MI which was sig-
nificantly greater than at 3 days (SNR=0.44 [IQR, 0.39–
0.67]; P<0.05), 14 days (SNR=0.30 [IQR, 0.23–0.34]; 
P<0.01). At 21 days post-MI (SNR=0.18 [IQR, 0.15–0.28] 
the 19F signal was negligible and significantly lower com-
pared with 3 days (P<0.05) and 7 days (P<0.001), con-
sistent with the resolution of inflammation. 19F signal 
was also detected at the site of thoracotomy, in the liver 
and lymph nodes, as these are major sites of macro-
phage clearance. Although the spleen was outside our 
imaging volume, PFC uptake would be also expected in 
this organ (as seen by other studies).16
To verify the in vivo results and to quantify the evo-
lution of the 19F signal, infarcted and remote areas 
were dissected and separated for ex vivo NMR spec-
troscopy acquired on whole tissue samples. NMR 
spectra were in good agreement with the in vivo MRI 
findings, where infarcted regions showed high PFC 
signal that was absent in the remote myocardium (Fig-
ure 3C). NMR analysis showed a maximum 19F concen-
tration (mmol/g tissue) at 7 days post-MI ([19F]=0.12 
[IQR, 0.075–0.18]; P<0.05) that was significantly 
higher compared with 21 days post-MI ([19F]=0.0063 
[IQR, 0.0042–0.020]). At 7 days post-MI the uptake in 
the region of infarcted myocardium was significantly 
greater than both remote myocardium ([19F]=0.026 
[IQR, 0.015–0.057]; P<0.05) and healthy hearts from 
SHAM-operated animals ([19F]=0.012 [IQR, 0.0042–
0.044]; P<0.05). At 21 days post-MI, the signal in the 
remote myocardium was statistically different from 
SHAM-operated animals. In SHAM-operated animals 
injected with PFC, no 19F signal was detected in the 
heart. A linear correlation was observed between in 
vivo MRI measurements and ex vivo NMR 19F signal 
measurements (ρ=0.58; P=0.020; Figure I in the Data 
Supplement).
MAC-3 IHC for identification of myocardial tissue 
macrophages showed recruitment of these cells into 
the infarcted area at the early stages after MI but not 
to the remote myocardium as seen by in vivo imag-
ing (Figure 3A). The number of MAC-3 positive mac-
rophages was significantly higher at 3 days post-MI 
(IHCMAC-3[%]=2.12 [IQR, 1.88–2.63]; P<0.05) and 7 days 
post-MI (IHCMAC-3[%]=3.65 [IQR, 2.74–4.09]; P<0.01) 
compared with SHAM animals (IHCMAC-3[%]=0.003 
[IQR, 0.002–0.004]) and was significantly higher 
at 7 days post-MI compared with 21 days post-MI 
(IHCMAC-3[%]=0.13 [IQR, 0.041–0.23]; P<0.05; Fig-
ure  3D). There was a significant correlation between 
the in vivo 19F MRI signal and macrophage content as 
quantified by IHC (ρ=0.89; P<0.0001; Figure 3E).
Assessment of Elastin Remodeling Post-
MI Using Gd-ESMA
ECM remodeling post-MI was evaluated using Gd-
ESMA, a contrast agent that binds to both cross-linked 
Figure 2. Functional and volumetric parameters of the heart at 3, 7, 14, and 21 days post-myocardial infarction (MI) and SHAM-operated mice.  
A, Representative anatomic short-axis images of the heart. Myocardium is depicted in orange; the star indicates myocardial wall thinning at day 21. B, Left 
ventricular end-diastolic volume progressively dilates from acute to late stages of MI. C, Increasing Left ventricular mass and (D) decreasing ejection fraction were 
observed over time. N=8 MI animals/time-point, N=4 SHAM-operated animals/time-point. *P<0.05, **P<0.01.
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Figure 3. Assessment of inflammatory response after myocardial infarction in mice at 3T magnetic resonance imaging (MRI) using  
19F perfluorocarbons.  
A, Representative short-axis views of coregistered 1H+19F images (left column; N=8 MI animals/time-point; N=6 SHAM-operated animals/time-point) and macro-
phage immunohistochemistry (IHC; macrophages identified as MAC-3 positive, brown; N=4 MI animals/time-point; N=3 SHAM-operated animals/time-point) from 
the heart at 3, 7, 14, and 21 days after MI. B, In vivo 19F MRI signal quantification. C, Ex vivo, 19F nuclear magnetic resonance (NMR) signal quantification (N=4/ 
time-point, N=3 SHAM-operated animals). D, IHC macrophages quantification shown a significant decrease between 7 and 21 days after infarct. E, Correlation be-
tween ex vivo macrophages IHC and in vivo 19F MRI signal. Spearman correlation (N=20, ρ=0.89, P<0.0001). Scale bar, 50 μm. *P<0.05, **P<0.01, ***P<0.001. 
IHC indicates immunohistochemistry.
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elastin and immature tropoelastin.17,18 One hour post-
Gd-ESMA injection, infarcted areas were enhanced 
at all time-points post-MI, allowing quantification of 
infarct size. Trichrome staining was performed and used 
to quantify infarct size ex vivo. There was a strong lin-
ear correlation between infarct size measured by in vivo 
MRI and histology (ρ=0.85; P<0.0001; Figure II in the 
Data Supplement).
To understand the contribution of fluid accumula-
tion in the interstitial space to the MR signal early after 
MI, myocardial edema was assessed using a T2-weight-
ed sequence.19–21 The high signal was observed at day 
3 but not at day 7 post-MI. The signal intensity seen 
on T2-weighted images at day 3 was associated with 
edema and increased extracellular volume, but did not 
reflect deposition of elastin/tropoelastin as confirmed 
by histology (Figure 4).
In vivo quantification of Gd-ESMA uptake was 
performed using a Modified Look-Locker inversion 
T1-mapping sequence. Relaxation rate (R1) maps 
showed uptake of Gd-ESMA in the infarcted area 
(increased R1) at 3, 7, 14, and 21 days post-MI, where-
as no enhancement was observed in the remote myo-
cardium (infarct versus remote, P<0.01, Figure 5B) nor 
in the SHAM-operated animals (infarct versus SHAM, 
P<0.001, Figure 5B). R1 values were also significantly 
higher within the infarct area at 21 days (R1 [s
−1]=2.83 
[IQR, 2.69–3.30]; P<0.05) compared with 7 days (R1 
[s−1]=2.3 [IQR, 2.12–2.5]).
To analyze the deposition of elastin fibers in the 
heart after MI, Elastica van Gieson staining was per-
formed. Mature fibers could be visualized, however, 
quantification was challenging (Figure III in the Data 
Supplement). For that reason, tropoelastin IHC was 
performed (Figure 5A and 5C) revealing a dense fiber 
network within the infarcted myocardium at 14 and 
21 days post-MI but not in the remote myocardium. 
Tropoelastin deposition was significantly higher at 
both 14 days (IHCTropoelastin[%]=2.78 [IQR, 2.51–3.07]) 
and 21 days (IHCTropoelastin[%]=3.25 [IQR, 2.87–3.45]) 
compared with SHAM (IHCTropoelastin[%]=0.14 [IQR, 
0.13–0.15], P<0.01). For the reason abovementioned, 
the 3 days’ time-point was excluded from the correla-
tion analysis between R1 and tropoelastin IHC analy-
ses. There was a statistically significant correlation 
between R1 values from 7, 14, and 21 days measured 
in vivo and ex vivo IHC analysis (ρ=0.89; P<0.0001; 
Figure 5D).
19F Versus R1 Can Be Used to Predict 
Cardiac Remodeling: Longitudinal Study
Remodeling post-MI is a dynamic and complex process. 
To understand the potential prognostic value of in vivo 
19F and Gd-ESMA MRI, a longitudinal proof-of-principle 
study was performed. Fifteen animals were scanned 
twice at days 7 and 21 post-MI. 19F MRI was performed 
at 7 days post-MI to assess the peak in the inflamma-
tory response and MRI with Gd-ESMA was performed 
at days 7 and 21 post-MI. No correlation was found 
between 19F at day 7 post-MI and Gd-ESMA uptake at 
day 7 (Figure 6A) and at day 21 post-MI (Figure 6B), 
suggesting that these biological processes are indepen-
dent/decoupled from each other.
The presence of elastin at day 7 (measured as R1) 
showed a linear correlation with the EDV measured at 
day 21, suggesting that early accumulation of elastin/
tropoelastin (larger Gd-ESMA uptake at day 7) might 
not be beneficial for the healing of the myocardium 
at day 21 (Figure  7A). In contrast, the inflammatory 
process measured at day 7 showed a more complex 
behavior (second-order polynomial model regression 
showed significant correlation than the linear model 
(P=0.030). PFCs data suggest that an optimal inflam-
matory response was observed for a 19F signal range 
between 0.55 and 1.85. Both an increased (19F>>1.85) 
or weak (19F<<0.55) inflammatory response at early 
stages post-MI resulted in large EDV (EDV>100 μL) at 
day 21 suggesting adverse cardiac outcome (Figure 7B).
The prognostic value of the 19F signal (19F SNR) 
and quantitative assessment of elastin/tropoelas-
tin deposition (R1) was investigated with receiver 
Figure 4. Assessment of elastin/tropoelas-
tin and myocardial edema in mice with 
myocardial infarction.  
A, Tropoelastin immunohistochemistry (IHC) 
and Elastica van Gieson (black staining) reveal 
the absence of protein deposition within the 
heart at 3 days, starting to accumulate at day 
7 (arrows). B, T2-weighted images showing 
high-signal intensity on the lateral wall (top 
images); Contrast-enhanced image (late 
gadolinium enhancement) showing high-
signal intensity in the infarcted areas (middle 
images). Scale bar, 25 μm.
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operating characteristic analysis (Figure IV in the 
Data Supplement). Both measurements carry some 
predictive value (R1<2.34: [Sens(%)+IC95%]=54.5 
[22.0–87.0]; [Specif(%)+IC95%]=100 [92.1–100.0]; 
0.55<19F<1.85: [Sens(%)+IC95%]=50 [20.5–79.5]; 
[Specif(%)+IC95%]=82 [59.3–100.0]) but the com-
bination of both improved the sensitivity and 
specificity in identifying animals that underwent 
Figure 5. In vivo imaging of extracellular matrix remodeling after myocardial infarction with a gadolinium-based elastin/tropoelastin-specific  
contrast agent.  
A, Representative short-axis images of relaxation rate (R1, left columns) maps and tropoelastin immunohistochemistry (IHC; right columns) of the hearts sections 
at 7, 14, and 21 days post-myocardial infarction (MI) at 3T magnetic resonance imaging (MRI). Tropoelastin fibers were identified as black fine fiber network. B, 
Quantification of the R1 in the infarct, remote myocardium (N=8/time-point) and in SHAM-operated animals (N=6 per time-point). R1 values increased significantly 
from 7 to 21 days post-MI. C, IHC quantification, showing a significant increase in tropoelastin fibers from 7 to 21 days post-MI (N=4/time-point; N=3 SHAM; 
PKruskal-Wallis SHAM vs 21 days <0.01). D, Correlation between ex vivo measurements of tropoelastin IHC and in vivo R1 values of the scar. Spearman correlation 
(N=16, ρ=0.89, P<0.0001). Scale bar, 50 μm. *P<0.05, **P<0.01, ***P<0.001.
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favorable myocardial remodeling post-MI (R1<2.34 and 
0.55<19F<1.85: [Sens(%)+IC95%]=75 [49.4–100.0], 
[Specif(%)+IC95%]=91 [74.1–100.0]). Logistic regres-
sion analysis using the increase of EDV at day 21 (dys-
functional remodeling) or the decrease of EDV at day 
21 (beneficial remodeling) as outcome result, showed 
that R1 at day 7 and 
19F at day 7 were not signifi-
cant predictors by themselves (P=0.68 and P=0.062, 
respectively). However, the combination of both mea-
surement results in an odds ratio of 30.0 (CI 95%, 
1.41–638.15; P=0.029).
DISCUSSION
In this cross-sectional study we showed that (1) PFCs 
19F MRI can be used to assess and monitor inflamma-
tory cell recruitment in vivo in the injured myocardium 
at a clinical field strength, as confirmed by ex vivo 
NMR and histological studies; (2) Gd-ESMA MRI allows 
quantification and visualization of scar size and elastin/
tropoelastin deposition in the myocardium during the 
scar maturation phase; and (3) in a longitudinal proof-
of-concept study, we further investigated the merits of 
Figure 6. Correlation between 19F signal and Gd-ESMA.  
There is no correlation between 19F signal at day 7 and (A) Gd-ESMA uptake 7 days after myocardial infarction (MI) and (B) gadolinium-based elastin/tropoelastin 
specific MR contrast agent (Gd-ESMA) uptake in the infarcted myocardium at day 21 post-MI.
Figure 7. Correlation between end-diastolic volume (EDV) at day 21 and R1 values and 19F signal at day 7.  
A, Linear correlation was found between EDV and R1 (gadolinium-based elastin/tropoelastin specific MR contrast agent [Gd-ESMA] uptake). B, Quadratic regres-
sion was found between EDV and 19F signal-to-noise ratio (SNR).
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both biomarkers for the prediction of the amount of 
cardiac remodeling (measured as EDV). We found that 
at the early stages post-MI a weak or strong inflamma-
tory response results in dysfunctional MI healing and 
that increased elastin/tropoelastin deposition within 
the scar tissue at the 7 day’s time-point is detrimental 
for cardiac remodeling. Our results suggest that multi-
nuclear 19F/1H MRI may provide a better understanding 
of the biological processes underlying post-MI remodel-
ing in vivo and PFCs and Gd-ESMA may serve as new 
imaging biomarkers for monitoring the progression of 
cardiac disease and allow predicting outcome.
Within the first week after MI inflammatory cells are 
recruited to the site of injury. Phagocytes avidly take 
up PFCs, which can be imaged by 19F MRI with excel-
lent contrast and without unwanted background sig-
nal, as shown previously.11,14,22,23 However, no study has 
described the temporal evolution of 19F signal in vivo 
at clinical field strength. Here we investigated the time 
course of inflammation using PFCs in vivo in a model of 
MI and related with the presence of immune cells. We 
successfully demonstrated the noninvasive visualiza-
tion and quantification of inflammatory cells with PFCs 
in the infarcted region in a murine model of MI by in 
vivo MRI, validated ex vivo by NMR. MRI signal inten-
sity measurements demonstrated that 19F is detect-
able within the first-week post-MI, with a peak at 7 
days, and importantly, PFC accumulation was restrict-
ed only to the infarcted region. Consistent with these 
findings, histological analysis showed that monocyte/
macrophage populations are significantly increased up 
to 7 days after LAD occlusion as detected by immune 
positive MAC-3 staining and, furthermore, we found a 
strong correlation between MAC-3 and 19F MRI signal. 
Our results are also in good agreement with the reso-
lution of inflammatory response at days 14 and 21 as 
described in animal models of MI.2,24,25
Noninvasive imaging of inflammatory cells recruit-
ment to the injured and remote myocardium has 
been shown by positron emission tomography in 
vivo26 but requires special patient preparation to sup-
press myocardial glucose metabolism. Alternatively, 
magnetic nanoparticles have been used for macro-
phage imaging post-MI in vivo27; however, despite 
their excellent sensitivity, they generate negative con-
trast because of shortened T2/T2* relaxation times of 
nearby water protons, creating hypointense regions 
and consequently making quantification challenging. 
Moreover, magnetic nanoparticles cannot be used in 
combination with other Gd-based contrast agents. In 
contrast, PFCs are detected directly and, therefore, 
generate positive signal contrast, and more impor-
tantly can be imaged simultaneously with, for exam-
ple, Gd-based contrast agents affecting only the 
extracellular 1H signal while 19F PFCs will be located 
intracellularly after phagocytosis. The potential of 19F 
particles has been extensively explored in preclinical 
models; they are chemically stable and can be fur-
ther functionalized by adding fluorochromes, thus 
allowing multimodal imaging (eg, MRI and fluores-
cence imaging). In this work, we did not investigate 
if PFCs can differentiate between the monocyte/mac-
rophage subpopulations (Ly6Chigh versus Ly6Clow; M1 
versus M2) during post-MI remodeling in vivo, which 
would be of great interest. Previous publications have 
suggested the recruitment of macrophages to the 
remote myocardium26,27; here, because of sensitivity 
we could not detect myocardial leukocyte enrich-
ment. Nevertheless, 19F MRI may provide an in vivo 
readout for monitoring treatment-related changes in 
total inflammatory cell infiltration.
As the inflammatory process dissipates, fibrotic tis-
sue accumulates in the infarcted regions and is then 
replaced by ECM proteins. Scar tissue formation com-
mences as early as 1-week post-MI and is mainly com-
posed of collagen type I but also elastin. Elastin is an 
insoluble protein that has been associated with scar for-
mation and stabilization.8,28,29 Mature elastin is formed 
by cross-linking of its soluble precursor, tropoelastin. 
Here, we took advantage of the increasing expression 
of elastin/tropoelastin during post-MI remodeling and 
investigated the use of Gd-ESMA as an imaging bio-
marker for the assessment of ECM remodeling. Elastin/
tropoelastin was quantified using T1 mapping to mea-
sure R1 after Gd-ESMA injection with 3T MRI. R1 values 
significantly increased from 7 to 21 days post-MI, which 
was in good agreement with the deposition of tropo-
elastin in the infarcted area measured by histology. At 3 
days post-MI, T1 mapping showed a significant increase 
in R1 in the infarcted area, however, histology showed a 
lack of elastin/tropoelastin at this time point. We hypoth-
esized that Gd-ESMA acts similarly to other gadolinium-
based contrast agents because of its small size,17,30 and 
immediately after MI its retention within the infarcted 
region may be unspecific and attributed to edema, cel-
lular swelling and rupture, and subsequent increase 
in extracellular volume, as previously shown in dogs 
and humans.19–21 Consistent with this hypothesis, we 
observed a high-signal intensity on native T2-weighted 
images at day 3 (high water content) in the infarcted 
area, which decreased at day 7 post-MI. Additionally, 
Gd-ESMA not only binds to tropoelastin and elastin 
(41%, KD=9.2±0.7 μM; 40%, KD=1.0±0.5 μM, respec-
tively) but also to other proteins, including BSA (15%, 
KD=ns) and chondroitin sulfates (5%, KD=ns),
31,32 collagen 
types I and III (22%, KD=7.3±1.3 μM; 13%, KD=6.8±1.2 
μM, respectively)18 that might be present at day 3, thus 
increasing its retention and tissue relaxation.
Gd-ESMA has been successfully used for molecular 
imaging of vessel wall elastin in atherosclerosis (30–32), 
and myocardial scar.15 ECM remodeling could also be 
assessed with alternative contrast agents specific for 
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other matrix proteins such as collagen thereby pro-
viding additional biological information in addition to 
standard LGE-MRI.
The recovery of cardiac function after MI is highly 
dependent on a balanced inflammatory response and 
on the deposition of ECM proteins within the heart. 
In our longitudinal proof-of-principle study the impact 
of the inflammatory response on LV remodeling was 
evaluated with PFCs and ECM remodeling with Gd-
ESMA MRI. A moderate inflammatory response at day 
3 (intermediate 19F signal) was associated with a bet-
ter LV remodeling at day 21 (measured as EDV). The 
healing process is affected by the exposure and dura-
tion of acute inflammation. Prolonged and exacerbated 
inflammation has been related to worse prognosis and 
similarly, the lack of inflammation has been associated 
with thinner infarcts, where the myocardium is more 
likely to rupture.3,4 A certain degree of inflammation 
and a controlled recruitment of monocyte/macro-
phages populations seems to be desired for optimal MI 
healing. Likewise, Sahul et al33 have shown that mod-
erate amounts of metalloproteinases in the infarcted 
region lead to lower LV remodeling in a pig model 
of MI. Inflammatory cell migration toward the infarct 
requires the presence of metalloproteinases to facilitate 
migration. Interestingly, while metalloproteinases are 
crucial for the recruitment of inflammatory cells, this 
study has shown that excessive metalloproteinases acti-
vation leads to LV expansion.
Here, we also have shown that higher R
1 values at 7 
days (high elastin/tropoelastin deposition) were associ-
ated with an unfavorable prognosis at 21 days post-
MI (high EDV). In previous work, Gd-ESMA has also 
been used to assess elastin deposition in the heart in 
a mouse model of MI. In their cross-sectional study, 
Wildgruber et al17 found that a higher contrast to 
noise ratio between scar and remote myocardium at 
day 21 correlated with a higher ejection fraction at the 
same time point, whereas the contrast to noise ratio at 
day 7 did not predict outcome at day 21. In contrast, 
we performed a longitudinal study, using T1 mapping 
and EDV as a readout for LV remodeling. Other stud-
ies showed that modifying the composition of myo-
cardial scar by exogenously increasing elastin content, 
cardiac function was improved after MI in rats.7–9 Also, 
increased expression of elastin via cell-based gene 
therapy improved cardiac function and survival of isch-
emic hearts in a rat model of MI.8,34 Further studies are 
needed to pinpoint the long-term role of elastin turn-
over/metabolism and cross-linking after MI.
Finally, we have also shown that the combination of 
the R1 at day 7 and 
19F at day 7 could predict the benefi-
cial or dysfunctional LV remodeling, although the odds 
ratio is statistically significant, it has a wide CI, which 
reflex the complex process of inflammation and remod-
eling, further studies, including bigger sample size and 
different animal models, have to be used to validate 
this conclusion.
Overall, multinuclear 19F/1H MRI may improve our 
knowledge of cardiac remodeling in vivo by targeting 
key biological processes that are responsible for post-
MI remodeling. This imaging protocol may be useful for 
risk stratification or to facilitate the in vivo study of the 
effects of novel therapeutic procedures in disease pro-
gression and potentially personalization of therapy.
LIMITATIONS
This study has shown the feasibility of multinuclear 
imaging in a murine model of post-MI remodeling via 
LAD ligation. 19F imaging was performed in a small-
animal model using a clinical 3T MR scanner, where 
high amounts of PFCs (ie, 3 mmol PFC per kilogram 
body weight) are required to generate enough sig-
nal. The high-dosage enabled visualization of PFCs in 
small structures such as the murine heart. For early 
time-points 19F deposition colocalized with LGE-ESMA 
enhancement within the scar area; however, for days 
14 and 21 LGE-ESMA images were used as guide for 
the analysis of PFC uptake. Direct quantification of PFCs 
from the MRI could not be performed, as a surface coil 
was used. However, with the use of NMR experiments 
at 9.4T we were able to quantify PFCs content both 
in the remote and infarcted myocardium ex vivo. As 
PFCs used in this study were not specific for macro-
phages, signal accumulation in the infarct area might 
also be because of other cells with phagocytic capacity. 
PFC accumulation is not specific for myocardial inflam-
mation but can also occur at other sites of inflamma-
tion (thoracotomy) and organs with high amounts of 
inflammatory and phagocytic cells such as the liver 
and lymph nodes. The here used PFCs did not allow 
to differentiate between the monocyte/macrophage 
subpopulations (Ly6Chigh versus Ly6Clow; M1 versus M2) 
during post-MI remodeling in vivo. PFC injection did 
not show any adverse effects in the animals throughout 
the period of time animals were monitored. However, 
PFCs have long-retention time in the body, making it 
challenging to obtain approval for clinical application. 
Further, improvement of the PFC nanoparticles biodis-
tribution properties, while maintaining their specific-
ity for macrophages could aid future use in humans. 
Additionally, in our study, we used a higher the dose 
of Gd-ESMA (0.5 mmol/kg) compared with that used 
in other animal models (0.2 mmol/kg) or nontargeted 
gadolinium-based agents in clinical studies. Future 
experiments will require dose optimization in MI mod-
els or humans; however, no toxic effects have been 
observed in the animals at any time-point. Finally, we 
used a permanent LAD occlusion model demonstrat-
ing a strong acute inflammatory response for proof-
of-concept 19F/1H MRI of myocardial inflammation 
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and remodeling after MI. In future studies, a reperfu-
sion model will be investigated, as it is more clinically 
relevant. The permanent LAD occlusion model only 
produces a mild inflammatory response, whereas the 
reperfusion model typically results in a stronger inflam-
matory response. Although the inflammatory response 
was weaker in our model we were able to detect and 
quantify both inflammation and ECM deposition in the 
infarct zone, making these contrast agents promising 
biomarkers for future studies.
CONCLUSIONS
We successfully demonstrated the feasibility of multi-
nuclear 1H/19F MRI to noninvasively assess and quantify 
the inflammatory response and evaluate elastin forma-
tion after post-MI remodeling in a murine model in vivo. 
We further studied the interplay between these biologi-
cal processes and correlated those with LV remodeling. 
This novel approach has potential for monitoring treat-
ment effects that aim to modulate the inflammatory or 
elastin responses in vivo and may aid the prognosis of 
cardiovascular diseases.
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